Eisai
4523.T
#2140
Rank
ยฃ6.72 B
Marketcap
ยฃ23.81
Share price
3.73%
Change (1 day)
9.70%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): ยฃ1.80

According to Eisai's latest financial reports the company's current EPS (TTM) is ยฃ0.65. In 2022 the company made an earnings per share (EPS) of ยฃ1.20 a decrease over its 2021 EPS that were of ยฃ5.31.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)ยฃ1.8050.59%
2022ยฃ1.20-77.48%
2021ยฃ5.31-41.88%
2020ยฃ9.14-0.94%
2019ยฃ9.2352.59%
2018ยฃ6.05124.17%
2017ยฃ2.70-49.42%
2016ยฃ5.3437.08%
2015ยฃ3.89-11.75%
2014ยฃ4.41-3.23%
2013ยฃ4.56-18.56%
2012ยฃ5.60-15.51%
2011ยฃ6.62-3.75%
2010ยฃ6.88-1.36%
2009ยฃ6.98